KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 106 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $225,000 | -63.6% | 12,140 | -65.3% | 0.07% | -59.1% |
Q4 2020 | $618,000 | +15.5% | 34,950 | 0.0% | 0.18% | +3.5% |
Q3 2020 | $535,000 | -32.0% | 34,950 | +13.2% | 0.17% | -36.3% |
Q2 2020 | $787,000 | +162.3% | 30,870 | +188.7% | 0.27% | +217.9% |
Q4 2018 | $300,000 | – | 10,694 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,025,000 | $12,064,000 | 2.56% |
GREAT POINT PARTNERS LLC | 536,738 | $6,317,000 | 1.40% |
Endurant Capital Management LP | 244,125 | $2,873,000 | 0.69% |
HHLR ADVISORS, LTD. | 2,920,023 | $34,369,000 | 0.53% |
Integral Health Asset Management, LLC | 140,000 | $1,648,000 | 0.46% |
Spearhead Capital Advisors, LLC | 235,024 | $2,766,000 | 0.33% |
Jackson Creek Investment Advisors LLC | 77,069 | $907,000 | 0.32% |
RICE HALL JAMES & ASSOCIATES, LLC | 712,807 | $8,390,000 | 0.30% |
Parkman Healthcare Partners LLC | 113,644 | $1,338,000 | 0.30% |
Birchview Capital, LP | 30,000 | $353,000 | 0.23% |